# Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents

> **NCT00156143** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 90 (—)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **PROCEDURE:** Blood sample
- **PROCEDURE:** Radiography

## Key facts

- **NCT ID:** NCT00156143
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 90 (—)
- **Last updated:** 2007-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00156143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00156143, "Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00156143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*